Andrés Muñoz-Martín

22PUBLICATIONS
97CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

|Mar 31, 2026
Existing challenges in the management of cholangiocarcinoma in Spain.

Andrés Jesús Muñoz Martín, Angela Lamarca, Jesus M Banales

|Nov 18, 2025
Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.

Mercedes Salgado, Juan de la Camara-Gómez, Ignacio García-Escobar

|Sep 30, 2025
Budget impact analysis of new drugs in oncology and haematology: Principles and practice.

Javier Soto-Alsar, José L Revuelta-Herrero, Cristina Villanueva-Bueno

|Apr 26, 2025
External validation of a prediction model for bleeding events in anticoagulated cancer patients with venous thromboembolism (PredictAI).

María Carmen Viñuela-Benéitez, Claudia Iglesias Pérez, Laura Ortega Morán

|Nov 19, 2024
Correction: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

Andrés J Muñoz Martín, Ramón Lecumberri, Juan Carlos Souto

Pageof 4

Frequent Collaborators

5 joint publications

Pilar García-Alfonso

4 joint publications

José Manuel Soria

3 joint publications

Laura Ortega

3 joint publications

Enrique Gallardo